Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Phillips

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
BMC Research Notes|January 7, 2017
A preliminary study of a novel emergency department nursing triage simulation for research applicationsSteven L Dubovsky, Daniel Antonius, David G Ellis, et al.
Physiological Genomics|June 7, 2007
Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in miceJunwu Mu, Dawei Qu, Agata Bartczak, et al.
Transplantation|July 23, 2002
Improvement in rejection of human decay accelerating factor transgenic pig-to-primate renal xenografts with administration of rabbit antithymocyte serumAnand Ghanekar, Ginette Lajoie, Yigang Luo, et al.
Plos One|September 13, 2014
Support and Assessment for Fall Emergency Referrals (SAFER 1): cluster randomised trial of computerised clinical decision support for paramedicsHelen Anne Snooks, Ben Carter, Jeremy Dale, et al.
Circulation|July 7, 2005
Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenograftsMichael Mendicino, MingFeng Liu, Anand Ghanekar, et al.
Transplantation|January 25, 2003
Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGALRobert Zhong, Yigang Luo, Hongji Yang, et al.
Journal of Virology|October 17, 2006
Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J miceNadine De Albuquerque, Ehtesham Baig, Xuezhong Ma, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activityGary A Levy, Gord Adamson, M James Phillips, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitisItay Shalev, Kit Man Wong, Katharina Foerster, et al.
The Journal of Clinical Investigation|July 4, 2003
The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitisPhilip A Marsden, Qin Ning, Laisum S Fung, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
BMC Research Notes|January 7, 2017
A preliminary study of a novel emergency department nursing triage simulation for research applicationsSteven L Dubovsky, Daniel Antonius, David G Ellis, et al.
Physiological Genomics|June 7, 2007
Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in miceJunwu Mu, Dawei Qu, Agata Bartczak, et al.
Transplantation|July 23, 2002
Improvement in rejection of human decay accelerating factor transgenic pig-to-primate renal xenografts with administration of rabbit antithymocyte serumAnand Ghanekar, Ginette Lajoie, Yigang Luo, et al.
Plos One|September 13, 2014
Support and Assessment for Fall Emergency Referrals (SAFER 1): cluster randomised trial of computerised clinical decision support for paramedicsHelen Anne Snooks, Ben Carter, Jeremy Dale, et al.
Circulation|July 7, 2005
Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenograftsMichael Mendicino, MingFeng Liu, Anand Ghanekar, et al.
Transplantation|January 25, 2003
Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGALRobert Zhong, Yigang Luo, Hongji Yang, et al.
Journal of Virology|October 17, 2006
Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J miceNadine De Albuquerque, Ehtesham Baig, Xuezhong Ma, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activityGary A Levy, Gord Adamson, M James Phillips, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitisItay Shalev, Kit Man Wong, Katharina Foerster, et al.
The Journal of Clinical Investigation|July 4, 2003
The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitisPhilip A Marsden, Qin Ning, Laisum S Fung, et al.
Pageof 15